CLINICAL RESEARCH: BIOMARKERS
Renal Clearance of B-Type Natriuretic Peptide and Amino Terminal Pro-B-Type Natriuretic PeptideA Mechanistic Study in Hypertensive Subjects
Roland R.J. van Kimmenade, MD, PhD*, ,*,
James L. Januzzi, Jr, MD, FACC ,
Jaap A. Bakker, MSc ,
Alphonse J. Houben, PhD ,
Roger Rennenberg, MD ,
Abraham A. Kroon, MD, PhD ,
Harry J.G.M. Crijns, MD, PhD*,
Marja P. van Dieijen-Visser, PhD ,
Peter W. de Leeuw, MD, PhD and
Yigal M. Pinto, MD, PhD||
* Department of Cardiology, University Hospital Maastricht, the Netherlands
Department of Clinical Chemistry, University Hospital Maastricht, the Netherlands
Department of Internal Medicine, University Hospital Maastricht, the Netherlands
Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts
|| Heart Failure Research Center, Academic Medical Centre, Amsterdam, the Netherlands
Manuscript received July 8, 2008;
revised manuscript received September 26, 2008,
accepted November 16, 2008.
* Reprint requests and correspondence: Dr. Roland R. J. van Kimmenade, Department of Cardiology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, the Netherlands (Email: rolandvank{at}hotmail.com).
Objectives: This study sought to compare the renal clearance mechanisms of B-type natriuretic peptide (BNP) and amino terminal pro-B-type natriuretic peptide (NT-proBNP).
Background: The small molecular weight proteins (SMWPs) BNP and NT-proBNP both inversely correlate with glomerular filtration rate (GFR). Whether this association is causal or confounding is unknown and has been the basis of widespread speculation.
Methods: We combined measurements of BNP and NT-proBNP concentrations in the renal arteries and veins of 165 subjects undergoing renal arteriography with invasive renal plasma flow (RPF) measurements and echocardiography. Fractional extraction (FE) of BNP and NT-proBNP was computed.
Results: The BNP and NT-proBNP concentrations correlated similarly to GFR (r = –0.35 and r = –0.30, respectively; p < 0.001 for both) but the NT-proBNP/BNP serum ratio was negatively associated with GFR (r = –0.21, p = 0.008). Median FEBNP was 0.21 (interquartile range [IQR] 0.16 to 0.22) for left and 0.22 (IQR 0.17 to 0.29) for right kidneys. Median FENT-proBNP was 0.16 (IQR 0.09 to 20) for left and 0.18 (IQR 0.12 to 0.22) for right kidneys. The FEBNP correlated with GFR (left: r = 0.26, p = 0.008; right: r = 0.21, p = 0.03) as did FENT-proBNP (left: r = 0.25, p = 0.005; right: r = 0.20, p = 0.02). Although FEBNP and FENT-proBNP correlated strongly with each other (left: r = 0.66; right: r = 0.60; p < 0.001 for both), left and right FENT-proBNP/BNP ratios were not influenced by GFR (r = 0.10, p = 0.30 and r = 0.08, p = 0.43, respectively). Multivariate analyses confirmed that FE was not independently associated with BNP or NT-proBNP concentrations.
Conclusions: Contrary to widespread belief (but in line with the renal physiology of SMWP), BNP and NT-proBNP are equally dependent on renal function for their clearance.
Key Words: natriuretic peptides NT-proBNP BNP kidney renal function
|
Abbreviations and Acronyms
| | BNP = B-type natriuretic peptide | | CKD = chronic kidney disease | | FE = fractional extraction | | GFR = glomerular filtration rate | | IQR = interquartile range | | MAP = mean arterial pressure | | NT-proBNP = amino terminal pro-B-type natriuretic peptide | | RBF = renal blood flow | | RPF = renal plasma flow | | SMWP = small molecular weight protein |
|
Related Articles
-
Does Renal Clearance Differ Between the B-Type Natriuretic Peptides (BNP Versus NT-proBNP)?
- Suetonia C. Palmer and A. Mark Richards
J. Am. Coll. Cardiol. 2009 53: 891-892.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A35.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M Schou, U Alehagen, J P Goetze, F Gustafsson, and U Dahlstrom
Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals
Heart,
September 15, 2009;
95(18):
1514 - 1519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Palmer, T. G. Yandle, M. G. Nicholls, C. M. Frampton, and A. M. Richards
Regional clearance of amino-terminal pro-brain natriuretic peptide from human plasma
Eur J Heart Fail,
September 1, 2009;
11(9):
832 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C.M. Linssen, K. Damman, H. L. Hillege, G. Navis, D. J. van Veldhuisen, and A. A. Voors
Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure
Circulation,
July 7, 2009;
120(1):
35 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. deFilippi and R. H. Christenson
B-Type Natriuretic Peptide (BNP)/NT-proBNP and Renal Function: Is the Controversy Over?
Clin. Chem.,
July 1, 2009;
55(7):
1271 - 1273.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Palmer and A. M. Richards
Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)?
J. Am. Coll. Cardiol.,
March 10, 2009;
53(10):
891 - 892.
[Full Text]
[PDF]
|
 |
|
|